BlinkRx is a prescription access platform that connects patients to branded medications, ensuring transparent pricing and home delivery.
BlinkRx has raised $140.0M in total funding. The most recent round was Series D. The last funding was announced in November 2024.
BlinkRx's investors include BoxGroup, 8VC, Deerfield, 1789 Capital, The K Fund.
BlinkRx is headquartered in New York, United States.
BlinkRx is a prescription access platform that connects patients to branded medications, ensuring transparent pricing and home delivery.
BlinkRx is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BlinkRx — Funding & Investors." VCBacked, November 16, 2024, https://www.vcbacked.co/company/blinkrx. Accessed July 19, 2026.
VCBacked. (2024). BlinkRx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/blinkrx
{{cite web |title=BlinkRx — Funding & Investors |url=https://www.vcbacked.co/company/blinkrx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated